Name: UMIN ID:
Unique ID issued by UMIN | UMIN000016932 |
---|---|
Receipt number | R000019656 |
Scientific Title | Phase II clinical study of nab-paclitaxel for patients with recurrent advanced non-small cell lung cancer. |
Date of disclosure of the study information | 2015/03/26 |
Last modified on | 2023/04/01 23:40:37 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2015/03/26 23:09:24 | ||
2 | Update | 2015/03/26 23:13:35 | Condition Condition |
|
3 | Update | 2015/03/27 12:54:56 | Study ID_1 |
|
4 | Update | 2015/03/27 22:49:47 | Organization Organization Category of Funding Organization Nationality of Funding Organization Nationality of Funding Organization |
|
5 | Update | 2015/04/08 20:55:35 | Recruitment status |
|
6 | Update | 2015/10/02 22:37:52 | Randomization unit |
|
7 | Update | 2016/04/05 20:31:38 | Name of primary person or sponsor Organization |
|
8 | Update | 2016/09/27 21:00:03 | Institutions |
|
9 | Update | 2019/04/04 14:51:16 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Division Organization Organization Address Address Tel |
|
10 | Update | 2019/04/04 14:55:42 | Date of IRB Last follow-up date |
|
11 | Update | 2019/05/10 15:11:19 | Other related information |
|
12 | Update | 2019/06/06 15:09:59 | Recruitment status Other related information |
|
13 | Update | 2019/09/30 07:43:13 | Number of participants that the trial has enrolled |
|
14 | Update | 2020/03/29 10:46:57 | Other related information |
|
15 | Update | 2021/04/01 11:14:58 | Results |
|
16 | Update | 2022/03/31 11:21:14 | Other related information |
|
17 | Update | 2023/04/01 23:40:37 | Recruitment status Other related information Other related information |